Serum Tumor Marker Half-Life during Chemotherapy Allows Early Prediction of Complete Response and Survival in Nonseminomatous Germ Cell Tumors
作者： Nancy L. Geller , Jerome Nisselbaum , Guy C. Toner , George J. Bosl , Claire Tan
DOI:
关键词: Surgery 、 Proportional hazards model 、 Survival rate 、 Tumor marker 、 Half-life 、 Gastroenterology 、 Internal medicine 、 Testicle 、 Germ cell tumors 、 Medicine 、 Human chorionic gonadotropin 、 Chemotherapy
摘要: … , those who later achieved a complete response (CR) had a median … Lack of appropriate decay of serum tumor markers can … for germ cell tumor patients: prior complete response as an …
aacrjournals.org
researchgate.net 参考文章(26)
A Horwich, M J Peckham, Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis. Cancer treatment reports. ,vol. 70, pp. 1329- 1331 ,(1986)
Patti S. Reinhardt, SAS supplemental library user's guide SAS Institute. ,(1980)
Robert B. Golbery, Nancy L. Geller, Howard Scher, Nicholas J. Vogelzang, Jerome Nisselbaum, Willet F. Whitmore, B. J. Kennedy, George J. Bosl, Davor Vugrin, Constance Cirrincione, Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Research. ,vol. 43, pp. 3403- 3407 ,(1983)
Judith L. Vaitukaitis, Glenn D. Braunstein, Griff T. Ross, A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone American Journal of Obstetrics and Gynecology. ,vol. 113, pp. 751- 758 ,(1972) , 10.1016/0002-9378(72)90553-4
G J Bosl, N L Geller, D Bajorin, S P Leitner, A Yagoda, R B Golbey, H Scher, N J Vogelzang, J Auman, R Carey, A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. Journal of Clinical Oncology. ,vol. 6, pp. 1231- 1238 ,(1988) , 10.1200/JCO.1988.6.8.1231
Nancy L. Geller, George J. Bosl, Eva Y. W. Chan, Stage Migration and the Increasing Proportion of Complete Responders in Patients with Advanced Germ Cell Tumors Cancer Research. ,vol. 48, pp. 3524- 3527 ,(1988)
Robert H. Vessela, Nicholas J. Vogelzang, Paul H. Lange, B. J. Kennedy, Anne Goldman, Elwin E. Fraley, Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors. Cancer Research. ,vol. 42, pp. 4855- 4861 ,(1982)
Lawrence H Einhorn, Stephen D Williams, Patrick J Loehrer, Robert Birch, Ray Drasga, George Omura, F Anthony Greco, None, Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. Journal of Clinical Oncology. ,vol. 7, pp. 387- 391 ,(1989) , 10.1200/JCO.1989.7.3.387
Guy C. Toner, Nancy L. Geller, Shiow-Yun Lin, George J. Bosl, Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features Cancer. ,vol. 67, pp. 2049- 2057 ,(1991) , 10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H
Nancy L. Geller, George J. Bosl, Eva Y. W. Chan, Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors. Cancer. ,vol. 63, pp. 440- 445 ,(1989) , 10.1002/1097-0142(19890201)63:3<440::AID-CNCR2820630308>3.0.CO;2-7